Imaging biomarkers in multiple Sclerosis: From image analysis to population imaging

Area of Science:

• Computational neuroscience
• Medical image analysis
• Neuroimaging biomarkers

Background:

• Increasing medical imaging data outpaces computational analysis capabilities.
• Advances in computational neuroscience are essential for brain research, neurological disorder care, and drug design.
• Current neuroimaging struggles to detect subtle pathological changes, especially in normal-appearing brain tissues.

Discussion:

• Developing generic computational methodologies validated on diseases with appropriate infrastructures is critical.
• New research paradigms are needed to understand early disease phases and aggregate comprehensive data.
• Integrating imaging with clinical, biological, and genetic data enhances pathological representation.

Key Insights:

• Quantitative neuroimaging biomarkers are needed to track disease evolution at multiple levels.
• Early detection of pathological evolution is vital for preventing disease progression and evaluating therapies.
• Multiple Sclerosis (MS) serves as a case study for illustrating challenges in acute neuro-inflammatory pathology analysis.

Outlook:

• Future research will integrate temporal, cellular, structural, and morphological data.
• Advanced medical image analysis will improve the specificity of differentiating pathological stages.
• The field will evolve to incorporate larger scales of information for a more holistic understanding of neurological pathologies.